Bellevue Life Sciences Acquisition Corp.·4

Feb 16, 8:05 PM ET

REED STEVEN 4

4 · Bellevue Life Sciences Acquisition Corp. · Filed Feb 16, 2023

Insider Transaction Report

Form 4
Period: 2023-02-14
Transactions
  • Award

    Common Stock

    2023-02-14+20,00020,000 total
  • Award

    Warrant for Common Stock

    2023-02-14+20,00020,000 total
    Exercise: $11.50Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]Represents the shares transferred by Bellevue Global Life Sciences Investors LLC (the "Sponsor"), the sponsor of the Issuer, to Mr. Reed for his board service.
  • [F2]Represents the warrants to purchase a total of 20,000 shares of the Issuer, transferred from the Sponsor to Mr. Reed for his service as Chairman of the Board of Directors. Each warrant will become exercisable 30 days after the Issuer's initial business combination. Each warrant will expire five years after the completion of the Issuer's initial business combination, or earlier upon redemption or liquidation. Each warrant entitles the holder to purchase one share of common stock at a price of $11.50 per share, subject to adjustments.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION